Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001722411 | SCV000577294 | likely benign | not provided | 2020-06-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314845 | SCV000848371 | likely benign | Inborn genetic diseases | 2016-11-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000973841 | SCV001121625 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506190 | SCV002808359 | likely benign | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | 2022-01-10 | criteria provided, single submitter | clinical testing |